http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Doxorubicin에 과민반응을 보인 유방암 환자에서 성공적으로 시행한 Epirubicin 탈감작 요법
박한기 ( Han Ki Park ),김민혜 ( Min Hye Kim ),임경환 ( Kyung Whan Lim ),강민구 ( Min Koo Kang ),김병근 ( Byung Keun Kim ),김태완 ( Tae Wan Kim ),권재우 ( Jae Woo Kwon ),이소희 ( So Hee Lee ),이상민 ( Sang Min Lee ),김세훈 ( Se Hoo 대한천식알레르기학회 2009 천식 및 알레르기 Vol.29 No.2
Doxorubicin, a chemotherapeutic agent of the anthracycline family, has commonly been used to treat a wide range of cancers including leukemia, Hodgkin`s lymphoma, and cancers of the breast, uterus, ovary and bladder. Hypersensitivity is a rare adverse reaction to anthracyclines including daunorubicin, idarubicin and epirubicin. Although cross-reactivity among chemotherapeutic agents of the anthracycline family is not completely established, these agents are not clinically recommended if a patient has show hypersensitivity reaction to any anthracyclines. Desensitization is an alternative treatment option to overcome hypersensitivity reaction to anthracyclines, but cases of anthracycline desensitization have rarely been reported till now. We report successful epirubucin desensitization in a breast cancer patient with doxorubicin hypersensitivity. (Korean J Asthma Allergy Clin Immunol 2009;29:127-131)